Tag: Therapeutic Goods Administration

The Therapeutic Goods Administration (TGA) has approved a new AI software system that can screen for three major eye diseases ...

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children ...

In 2016, at his home RANZCO scientific branch meeting in Tasmania, preeminent ophthalmic genetics expert Professor Alex Hewitt presented on ...

Optometry Australia (OA) is urging caution for practices considering offering gifts or discounts to fully vaccinated patients as part of ...

Glaukos has secured Australian regulatory approval for the Preserflo MicroShunt, offering late-stage glaucoma patients a more elegant surgical alternative to ...

Allergan has secured regulatory approval for an alternative product to address a Prednefrin Forte shortage in Australia. The company confirmed ...

Australian optometrists are reporting positive results with a homegrown clinical decision support tool that uses artificial intelligence (AI) to analyse ...

The Therapeutic Goods Administration (TGA) has confirmed a shortage of Prednefrin Forte 10mL eye drops in Australia, which isn't expected ...

Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation ...

For 40 years laser therapy has been the standard treatment for proliferative diabetic retinopathy (PDR), but now Australian ophthalmologists have ...